Medichem Solutions S.L., a subsidiary of Medichem and a member of Catalonia.health, has announced a strategic collaboration with Breckenridge Pharmaceutical, Inc., a U.S.-based generic pharmaceutical company and subsidiary of Towa International.

Devicare, a leading pharmaceutical company in the field of urology and a member of Catalonia.health, has announced the acquisition of IP-6 International, Inc., a renowned North American nutritional supplement company and manufacturer of the IP6 Gold® brand. This operation represents Devicare's first acquisition outside Spain and constitutes a significant milestone in its international growth strategy.

The biotechnology company Orikine Bio, a member of Catalonia.health, has received €2.7 million in investment from SICC Innvierte of CDTI Innovación together with fund managers Asabys Partners (Sabadell Asabys Health Innovation Investments II, FCR and Sabadell Asabys Health Innovation Investments 2B, SCR SA) and AdBio Partners (AFB Seed Fund II), also members of Catalonia.health.

The Catalan ecosystem of emerging companies specialized in the health sector has achieved a new historic record in investment rounds. Funding raised through capital, grants and debt surged 60% year-on-year in 2025, reaching €378.2 million, with Catalonia.health member companies leading the main operations.

Asabys Partners, a venture capital firm based in Barcelona and a member of Catalonia.health, has announced the launch of Oriva Therapeutics, a company dedicated to developing innovative therapies in women's health. The new company has integrated two advanced assets from Oncostellae and Medibiofarma, targeting two chronic diseases with high unmet medical need: endometriosis and uterine fibroids.

Archivel Farma, a member of Catalonia.health, has announced the renewal of its GMP manufacturing certification, confirming compliance with the requirements of the new Annex 1 and Annex 2 to produce sterile, freeze-dried and biological products, in accordance with current European regulatory standards.

El passat 10 de febrer, catalonia.health va participar en la sessió "Explorant sinergies per a la salut global", una trobada de gran rellevància estratègica celebrada a ACCIÓ amb el Dr. Jarbas Barbosa da Silva Jr., director de la Pan American Health Organization (PAHO), l'organització que actua com a branca regional de la Organització Mundial de la Salut a l'hemisferi americà.

Els dies 8 i 9 de febrer, representants del sector biohealth català han participat en la segona edició delFIT4FUTURE Leaders Meeting celebrat a Bilbao, una trobada que ha reunit 14 territoris industrialsinnovadors d'Europa per definir el futur de la competitivitat industrial del continent.

Catalonia.health will participate in 4YFN 2026, the international event for startups and technology companies taking place from March 2 to 5 at Fira Gran Via in Barcelona, as part of the Mobile World Congress. 

The 12th edition brought together Catalonia's health ecosystem at the Gran Teatre del Liceu to celebrate innovation and the sector's collaborative spirit